Common Contracts

ASSET PURCHASE AGREEMENT BETWEEN TEVA PHARMACEUTICAL INDUSTRIES LTD. AND IMPAX LABORATORIES, INC. DATED AS OF JUNE 20, 2016

Asset Purchase Agreement • January 6th, 2017 • Impax Laboratories Inc • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  January 6th, 2017
• Company
  Impax Laboratories Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of June 20, 2016 (the “Effective Date”), is made by and between Impax Laboratories, Inc., a Delaware corporation (“Buyer”), and Teva Pharmaceutical Industries Ltd., an Israeli corporation, acting directly or through its Affiliates (“Seller”).

ASSET PURCHASE AGREEMENT BETWEEN TEVA PHARMACEUTICAL INDUSTRIES LTD. AND IMPAX LABORATORIES, INC. DATED AS OF JUNE 20, 2016

Asset Purchase Agreement • August 9th, 2016 • Impax Laboratories Inc • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  August 9th, 2016
• Company
  Impax Laboratories Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of June 20, 2016 (the “Effective Date”), is made by and between Impax Laboratories, Inc., a Delaware corporation (“Buyer”), and Teva Pharmaceutical Industries Ltd., an Israeli corporation, acting directly or through its Affiliates (“Seller”).